Biotech · page 2

Max Hodak, a co-founder of Neuralink, is scheduled to present his perspective on the impending obsolescence of screen-based interfaces at the TechCrunch Disrupt 2026 conference. Hodak's presentation will articulate a future where human-computer interaction moves beyond traditional displays, exploring…

Stanford University researchers have successfully integrated human brain cells into genetically modified mice, a breakthrough reported in the journal Nature. The study, led by neuroscientist Sergiu Pașca, involved genetically engineering mice to have underdeveloped cortices and hippocampi, creating space…

Europe is currently deliberating new guidelines for the cultivation of gene-edited plants, a move that could significantly impact agricultural practices and food production across the continent. The discussion centers on how to regulate crops developed using techniques like CRISPR-Cas9…

A groundbreaking neural device, detailed in a Nature publication on September 14, 2026, has demonstrated the ability to translate brain activity into intended speech and gestures in real time. This 'multifunctional' brain implant leverages artificial intelligence to interpret neural signals…

A new base editing strategy has demonstrated high efficiency in modifying the PCSK9 gene and supporting normal human embryo development, according to research published online on September 9, 2026, in the journal Nature.

MIT Technology Review has released its highly anticipated "35 Innovators Under 35" list for 2026, an annual recognition that celebrates the brightest young minds shaping the future of science and technology.

MIT Technology Review has announced its annual list of 35 Innovators Under 35, recognizing individuals under the age of 35 whose research and technical work are poised to shape the future of science and technology.

Two child fatalities in separate gene-therapy clinical trials in China have brought heightened scrutiny to the country's rapidly expanding biomedical industry, according to researchers. The first incident involved a 14-year-old boy who died in a trial for a gene therapy…

Two children have died in China following experimental gene therapies, a development that has prompted calls for enhanced public disclosure of such incidents and raises questions about the future of gene therapy research in the country.

MIT Technology Review has announced its 2026 list of 35 Innovators Under 35, highlighting individuals making significant contributions across science and technology. This annual recognition aims to provide insight into the future trajectory of scientific and technological advancements by showcasing…

Fast Company has unveiled its Best Workplaces for Innovators 2026 list, recognizing ten distinguished companies that are driving significant advancements within the dynamic biotech, healthcare, and life sciences sectors. A striking observation from this year's selection is the pronounced concentration…

A novel CRISPR-based gene editing therapy has demonstrated the ability to significantly reduce cholesterol levels in participants for a duration of at least 12 months. The findings, published online on September 1, 2026, in the journal Nature, stem…

Moderna's personalized cancer vaccine has demonstrated promising results in a recent clinical trial, offering a beacon of hope for individuals battling cancer. The trial's positive outcomes, published online on August 28, 2026, in Nature, underscore the potential of mRNA technology…

Researchers at MIT, in collaboration with Harvard and the University of Houston, have developed a novel approach to enhance the efficacy of mRNA cancer vaccines by amplifying the body's T-cell response.

A personalized mRNA vaccine designed to target melanoma has shown promising results in a recent clinical trial, according to a publication in Nature on August 21, 2026. This development offers a potential new avenue for cancer treatment by leveraging…

Dephy has expanded its Sidekick line of personal bionic footwear, introducing two distinct foot shapes engineered to facilitate powered walking. These advanced prosthetic devices are designed to transfer power generated by an ankle-worn device directly to the foot, enabling…

Belgian biotechnology company Argenx experienced a significant stock surge this week after announcing highly positive results from a Phase 3 clinical trial for its experimental drug, empasug. The trial evaluated the efficacy of empasug in treating generalized myasthenia gravis (gMG)…

Moderna's personalized mRNA cancer vaccine has shown promising results in a clinical trial, successfully preventing the recurrence of melanoma in patients. The study, published online on August 20, 2026, in Nature, indicates that the vaccine could be a significant advancement…

Human brain organoids were cultivated for more than five years in a laboratory setting, demonstrating that brain cells can continue to mature and record the passage of time. This research, published online in Nature on August 19, 2026…

Merck and Moderna announced on December 13, 2023, that their investigational mRNA cancer vaccine, in combination with Merck's immunotherapy Keytruda (pembrolizumab), demonstrated a statistically significant and clinically meaningful improvement in recurrence-free survival (RFS) for patients with stage III or IV…